Search - tctmd.com

Displaying 781 - 800 of 1522

Sort: Relevancy | Date

Aspirin Versus Aspirin Plus Clopidogrel as Antithrombotic Treatment Following Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve The ARTE Randomized Clinical Trial

Presentation EuroPCR 2017

The ARTE Randomized Clinical Trial

Presenter: Josep Rodés-Cabau

May 17, 2017

Presentation

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

April 25, 2017

Presentation

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

April 21, 2017

Presentation Fellows 2017

Antithrombin Therapy for the Interventionalist

Presenter: Manish A. Parikh, David J. Cohen

April 07, 2017

Presentation

Functional Testing or Coronary CT Angiographyin Patients With Stable CAD

April 03, 2017

Presentation SIF 2017

This Was Not Supposed to Happen!

Presenter: Douglas E. Drachman

March 10, 2017

Presentation SIF 2017

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

Presenter: Michael J. Rinaldi

March 10, 2017

Presentation SIF 2017

PCI Pharmacology in 2017: Understanding the Essentials

Presenter: MIchael A. Kutcher

March 09, 2017

Presentation

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

February 13, 2017

Presentation

New Oral Anticoagulants: Are the Best Options

Presenter: Roberta Rossini

February 10, 2017

Presentation JIM 2017

Lithoplasty for treatment of Calcified Coronary Disease: The results of the DISRUPT CAD study

Presenter: Todd J. Brinton

February 10, 2017

Presentation JIM 2017

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Presenter: Dominick J. Angiolillo

February 10, 2017

Presentation JIM 2017

Appendix Closure is the Solution

Presenter: Horst Sievert

February 10, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation JIM 2017

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Presenter: Giuseppe Tarantini

February 10, 2017

Presentation TCT 2016

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Presenter: Jonathan M. Hill, Christoph K. Naber, Manel Sabate

November 01, 2016

Presentation TCT 2016

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Presenter: Sanjay Kaul, Jeffrey J. Popma, John D. Puskas

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Hitinder S. Gurm

November 01, 2016

Presentation TCT 2016

2016 DAPT Update: Evidence and Guidelines

Presenter: Sripal Bangalore, George D. Dangas, Adnan K. Chhatriwalla

November 01, 2016

Presentation TCT 2016

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Presenter: David J. Cohen, Ajay J. Kirtane, Alan C. Yeung, Gennaro Giustino

November 01, 2016

Advertisement

The ARTE Randomized Clinical Trial

Incident MI and Very Late Stent Thrombosis in Outpatients With Stable CAD

FFR-Guided Complete Revascularization in Patients With STEMI and Severe Nonculprit Disease

Antithrombin Therapy for the Interventionalist

Functional Testing or Coronary CT Angiographyin Patients With Stable CAD

This Was Not Supposed to Happen!

Salvaging a Disaster: 78 yo Male prior CABG presents with Acute CHF

PCI Pharmacology in 2017: Understanding the Essentials

10-Year Clinical Outcome After Randomization to Sirolimus- or Paclitaxel-Eluting Coronary stents

New Oral Anticoagulants: Are the Best Options

Lithoplasty for treatment of Calcified Coronary Disease: The results of the DISRUPT CAD study

Intravenous P2Y12 Receptor Inhibitors: Now We Can Do It

Appendix Closure is the Solution

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Pre-treat or not to pre-treat with oral antiplatelets: This is the DUBIUS

Recommendations for P2Y12 Inhibitor Type, Loading and Duration With BRS in Stable CAD and ACS

Opening Salvo: Despite EXCEL And NOBLE, I Don't Believe PCI Should Be the Standard Revascularization Strategy for Most Patients With Left Main CAD!

Opening Salvo: I Don't Believe That Door-to-Balloon Time Is a Critical Metric for Primary PCI In 2016!

2016 DAPT Update: Evidence and Guidelines

Opening Salvo: I Don't Believe That DAPT Should Be Continued Beyond 12 Months in Most Patients Undergoing PCI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content